financetom
Business
financetom
/
Business
/
Lockheed Martin Shares Climb On Positive Analyst Ratings And Strong Q2 Results
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Lockheed Martin Shares Climb On Positive Analyst Ratings And Strong Q2 Results
Jul 24, 2024 12:48 PM

Lockheed Martin Corporation ( LMT ) shares are higher Wednesday after multiple analysts raised their price targets following the company’s second-quarter earnings.

What Happened: The aerospace and defense giant reported earnings per share (EPS) of $7.11 for Q2 2024, surpassing analysts’ expectations of $6.46. Additionally, revenue for the quarter reached $18.122 billion, exceeding the anticipated $17.044 billion.

Earnings Highlight

Revenue Growth: Consolidated revenue rose by 8.6%, surpassing both internal estimates and market consensus by 6.3%.

F-35 Program: Lockheed Martin ( LMT ) delivered 10 F-35 aircraft in July alone, with six featuring the TR-3 update and four with the TR-2 configuration. The company continues to project between 75 to 110 F-35 deliveries for 2024.

MFC Margins: Margins within the Missiles and Fire Control (MFC) segment provided an upside surprise. Despite recognizing only $100 million of the $325 million expected losses for the first half of 2024, the segment’s cost pressures suggest a potential margin decrease in the second half of the year.

Guidance and Outlook: Lockheed Martin ( LMT ) raised its 2024 guidance, increasing revenue projections by $1.75 billion and segment operating income by $175 million. Adjusted EPS guidance was also raised by $0.35 at the midpoint, though free cash flow expectations remain unchanged.

Analyst Reactions: Several analysts have responded positively to Lockheed Martin's ( LMT ) second-quarter results, revising their price targets and ratings:

TD Cowen: Upgraded Lockheed Martin ( LMT ) from Hold to Buy, raising the price target from $480 to $560.

Susquehanna: Maintained a Positive rating, increasing the price target from $540 to $565.

UBS: Kept a Neutral rating, raising the price target from $511 to $538.

Wells Fargo: Maintained an Equal-Weight rating, increasing the price target from $483 to $525.

RBC Capital: Held a Sector Perform rating, adjusting the price target from $470 to $500.

Deutsche Bank: Maintained a Hold rating, raising the price target from $487 to $540.

Price Action: Lockheed Martin’s shares climbed to $514.86, up by 2.71% according to Benzinga Pro.

See Also:

What’s Going On With Lululemon Stock?

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Guidewire Software Fiscal Q2 Non-GAAP EPS, Revenue Rise; 2025 Outlook Reiterated -- Shares Up Late
Guidewire Software Fiscal Q2 Non-GAAP EPS, Revenue Rise; 2025 Outlook Reiterated -- Shares Up Late
Mar 6, 2025
04:33 PM EST, 03/06/2025 (MT Newswires) -- Guidewire Software ( GWRE ) reported fiscal Q2 non-GAAP earnings late Thursday of $0.51 per diluted share, up from $0.46 a year earlier. Analysts polled by FactSet expected $0.52. Revenue for the quarter ended Jan. 31 rose to $289.5 million from $240.9 million a year earlier. Analysts surveyed by FactSet expected $285.5 million....
US FTC sues to block private equity buy of medical company
US FTC sues to block private equity buy of medical company
Mar 6, 2025
(Reuters) -The U.S. Federal Trade Commission sued on Thursday to block medical device coatings maker Surmodics' acquisition by private equity firm GTCR, saying the deal would contribute to high healthcare costs. The FTC said the deal would give the combined company more than 50% of the market for suppliers of hydrophilic coatings used to smooth surgical and internal medical devices...
Profound Medical Edges Down After Hours as Its Q4 Loss Narrows, Revenue Jumps 108%
Profound Medical Edges Down After Hours as Its Q4 Loss Narrows, Revenue Jumps 108%
Mar 6, 2025
04:32 PM EST, 03/06/2025 (MT Newswires) -- Profound Medical ( PROF ) edged down in after-hours Nasdaq after the company on THursday said its fourth-quarter narrowed as revenue more than doubled. The medical-device company said it US$4.9 million, or US$0.20 per share, in the period, compared with a loss of US$8.9 million, or US$0.42, in the prior-year period. Revenue surged...
Bain, CC Capital sweeten bid for Australia's Insignia to $2.1 billion
Bain, CC Capital sweeten bid for Australia's Insignia to $2.1 billion
Mar 6, 2025
(Reuters) - Australia's Insignia Financial ( IOOFF ) said on Friday it had received higher takeover offers from Bain Capital and CC Capital Partners, with both the private equity firms sweetening their bids to A$3.34 billion ($2.11 billion). ($1 = 1.5803 Australian dollars) (Reporting by Rishav Chatterjee in Bengaluru; Editing by Arun Koyyur) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved